297 related articles for article (PubMed ID: 27190245)
1. Programmable biomaterials for dynamic and responsive drug delivery.
Stejskalová A; Kiani MT; Almquist BD
Exp Biol Med (Maywood); 2016 May; 241(10):1127-37. PubMed ID: 27190245
[TBL] [Abstract][Full Text] [Related]
2. Dendrimers and dendritic polymers in drug delivery.
Gillies ER; Fréchet JM
Drug Discov Today; 2005 Jan; 10(1):35-43. PubMed ID: 15676297
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal delivery of bioactive molecules for wound healing using stimuli-responsive biomaterials.
Oliva N; Almquist BD
Adv Drug Deliv Rev; 2020; 161-162():22-41. PubMed ID: 32745497
[TBL] [Abstract][Full Text] [Related]
4. An overview of chitosan and its application in infectious diseases.
Meng Q; Sun Y; Cong H; Hu H; Xu FJ
Drug Deliv Transl Res; 2021 Aug; 11(4):1340-1351. PubMed ID: 33496926
[TBL] [Abstract][Full Text] [Related]
5. Identification of anti-infective targets through comparative proteomics.
Burchmore R
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):163-5. PubMed ID: 16597196
[No Abstract] [Full Text] [Related]
6. Drug resistance: a growing problem.
Peet NP
Drug Discov Today; 2010 Aug; 15(15-16):583-6. PubMed ID: 20434584
[No Abstract] [Full Text] [Related]
7. Recent advances in biomaterials for tissue engineering and controlled drug delivery.
Helary C; Desimone MF
Curr Pharm Biotechnol; 2015; 16(7):635-45. PubMed ID: 25934973
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable chitosan nanoparticles in drug delivery for infectious disease.
Landriscina A; Rosen J; Friedman AJ
Nanomedicine (Lond); 2015 May; 10(10):1609-19. PubMed ID: 26008195
[TBL] [Abstract][Full Text] [Related]
9. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
10. Drug-therapy networks and the prediction of novel drug targets.
Spiro Z; Kovacs IA; Csermely P
J Biol; 2008 Jul; 7(6):20. PubMed ID: 18710588
[TBL] [Abstract][Full Text] [Related]
11. Bone regeneration with biomaterials and active molecules delivery.
D' Este M; Eglin D; Alini M; Kyllonen L
Curr Pharm Biotechnol; 2015; 16(7):582-605. PubMed ID: 25658379
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial agents: the new theriac?
Labro MT
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1363-5. PubMed ID: 23253312
[No Abstract] [Full Text] [Related]
13. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
14. Layer-by-Layer Biomaterials for Drug Delivery.
Alkekhia D; Hammond PT; Shukla A
Annu Rev Biomed Eng; 2020 Jun; 22():1-24. PubMed ID: 32084319
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer targeting using conjugates biomaterial 5-flurouracil.
Jaferian S; Negahdari B; Eatemadi A
Biomed Pharmacother; 2016 Dec; 84():780-788. PubMed ID: 27721176
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.
Ang CY; Tan SY; Zhao Y
Org Biomol Chem; 2014 Jul; 12(27):4776-806. PubMed ID: 24737243
[TBL] [Abstract][Full Text] [Related]
17. Advanced materials and processing for drug delivery: the past and the future.
Zhang Y; Chan HF; Leong KW
Adv Drug Deliv Rev; 2013 Jan; 65(1):104-20. PubMed ID: 23088863
[TBL] [Abstract][Full Text] [Related]
18. Molecular vehicles for mitochondrial chemical biology and drug delivery.
Rin Jean S; Tulumello DV; Wisnovsky SP; Lei EK; Pereira MP; Kelley SO
ACS Chem Biol; 2014 Feb; 9(2):323-33. PubMed ID: 24410267
[TBL] [Abstract][Full Text] [Related]
19. Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.
Bose RJC; Ravikumar R; Karuppagounder V; Bennet D; Rangasamy S; Thandavarayan RA
Drug Discov Today; 2017 Aug; 22(8):1258-1265. PubMed ID: 28600191
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer.
Sankar R; Ravikumar V
Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
